Literature DB >> 18490729

Regulatory CD4+ T cells are crucial for preventing CD8+ T cell-mediated autoimmunity.

Maud Poitrasson-Rivière1, Boris Bienvenu, Armelle Le Campion, Chantal Bécourt, Bruno Martin, Bruno Lucas.   

Abstract

In vivo studies have shown that regulatory CD4(+) T cells regulate conventional CD4(+) T cell responses to self- and environmental Ags. However, it remains unclear whether regulatory CD4(+) T cells control CD8(+) T cell responses to self, directly, or indirectly by decreasing available CD4(+) T cell help. We have developed an experimental mouse model in which suppressive and helper T cells cannot mediate their functions. The mouse chimeras generated were not viable and rapidly developed multiple organ autoimmunity. These features were correlated with strong CD8(+) T cell activation and accumulation in both lymphoid and nonlymphoid organs. In vivo Ab treatment and secondary transfer experiments demonstrated that regulatory CD4(+) T cells play an important direct role in the prevention of peripheral CD8(+) T cell-mediated autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490729     DOI: 10.4049/jimmunol.180.11.7294

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity.

Authors:  Sabine Muth; Kristian Schütze; Hansjörg Schild; Hans Christian Probst
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

2.  A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.

Authors:  Marco Cardone; Karla Garcia; Mulualem E Tilahun; Lisa F Boyd; Sintayehu Gebreyohannes; Masahide Yano; Gregory Roderiquez; Adovi D Akue; Leslie Juengst; Elliot Mattson; Suryatheja Ananthula; Kannan Natarajan; Montserrat Puig; David H Margulies; Michael A Norcross
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.